Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 23 of 23 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 07/31/02
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 08/31/02
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 07/31/03
End: 08/31/04
Due: 08/31/05
Phase: N/A
Priority: Normal
Start: 08/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/04
End: 10/31/05
Due: 10/31/06
Phase: N/A
Priority: Normal
Start: 12/31/99
End: 08/31/06
Due: 08/31/07
Phase: N/A
Priority: Normal
Start: 09/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/04
End: 12/31/05
Due: 12/31/06
Phase: N/A
Priority: Normal
Start: 07/31/16
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 12/31/11
Due: 12/31/12
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 11/30/04
Due: 11/30/05
Phase: N/A
Priority: Normal
Start: 06/30/03
End: 09/30/06
Due: 09/30/07
Phase: N/A
Priority: Normal
Start: 09/13/22
End: 09/30/30
Due: 09/30/31
Phase: N/A
Priority: Normal
Start: 12/31/99
End: 10/31/04
Due: 10/31/05
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 10/31/06
Due: 10/31/07
Phase: N/A
Priority: Normal
Start: 08/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 06/30/12
Due: 06/30/13